Which diabetes medications can cause gastroparesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Diabetes medications that can cause or worsen gastroparesis include GLP-1 receptor agonists, such as exenatide, liraglutide, semaglutide, and dulaglutide, as well as amylin analogs like pramlintide, according to the most recent evidence 1. These medications work by slowing gastric emptying, which can exacerbate or trigger gastroparesis symptoms in susceptible individuals.

  • GLP-1 receptor agonists are the most commonly associated class of medications with gastroparesis.
  • Amylin analogs, such as pramlintide, also slow gastric emptying and may contribute to gastroparesis.
  • Other medications, such as SGLT-2 inhibitors, like empagliflozin or dapagliflozin, may also cause delayed gastric emptying, although this is less common.
  • Metformin, while generally well-tolerated, can cause gastrointestinal side effects that might be confused with gastroparesis symptoms. Individuals with diabetes who already have autonomic neuropathy affecting the digestive system are particularly vulnerable to developing medication-induced gastroparesis 1. If gastroparesis symptoms develop, healthcare providers may need to adjust medication dosages or switch to alternative diabetes treatments. The risk of removal of GLP-1 RAs should be balanced against their potential benefits, and other treatment options, such as domperidone and erythromycin, may be considered in severe cases 1.

From the Research

Diabetes Medications and Gastroparesis

The relationship between diabetes medications and gastroparesis is complex, with some medications potentially exacerbating or contributing to the condition.

  • Gastroparesis is a complication of diabetes characterized by delayed gastric emptying, which can lead to symptoms such as nausea, vomiting, and bloating 2.
  • Certain medications, including some used to treat diabetes, can slow gastric emptying and worsen gastroparesis symptoms 2.
  • However, the provided studies do not specifically identify which diabetes medications can cause gastroparesis, instead focusing on treatments for the condition, such as metoclopramide, erythromycin, and domperidone 3, 4, 5.

Treatment of Diabetic Gastroparesis

Treatment for diabetic gastroparesis often involves prokinetic agents, which help stimulate gastric emptying.

  • Erythromycin, a macrolide antibiotic, has been shown to be effective in treating diabetic gastroparesis by enhancing gastric emptying and improving glycemic control 4, 5.
  • Metoclopramide is another medication that has been used to treat diabetic gastroparesis, with studies demonstrating its ability to improve gastric emptying and reduce symptoms 3, 5.
  • Other treatments, such as gastric neuromodulation and surgical interventions, may also be considered for patients with medication-refractory diabetic gastroparesis 2.

Alternative Treatments

Complementary and alternative medical treatments, such as acupuncture and massage, are being explored as potential therapies for diabetic gastroparesis.

  • These treatments may offer fewer side effects and lower costs compared to traditional Western medical approaches 6.
  • However, more research is needed to fully understand the mechanisms and effectiveness of these alternative therapies in treating diabetic gastroparesis 6.

Related Questions

In a diabetic patient with gastroparesis, is it appropriate to initiate dapagliflozin and what precautions should be taken?
What are the recommended management strategies for gut motility disturbances, such as gastroparesis, constipation, and diarrhea, in patients with diabetes?
How should diabetic gastropathy (gastroparesis) be diagnosed and managed?
What is the dosage of erythromycin (Erythromycin) for the treatment of gastroparesis?
What are the most likely and most dangerous causes of bloating, abdominal pain, early satiety, nausea, and vomiting in a patient with a history of diabetes (Diabetes Mellitus) and recurrent diabetic ketoacidosis (DKA)?
What is the maximum recommended dose of diltiazem (calcium channel blocker) oral?
What medications can be discontinued in a hospice patient with metastatic colon cancer, diabetes, hypertension, hyperlipidemia, and obesity, taking aspirin, Lipitor (atorvastatin), hydrochlorothiazide, insulin glargine, insulin Lispro, and losartan?
What is the role of amiodarone in the critical care setting?
What size subdural hematoma (subdural hemorrhage) typically warrants consideration for craniotomy (surgical removal of part of the skull)
What are the typical lab findings in starvation ketosis?
What is the initial treatment for a 15-year-old male with hyperglycemia (elevated blood glucose), an HbA1c (hemoglobin A1c) level of 7.3, and acanthosis, without proteinuria (protein in the urine), ketonuria (ketones in the urine), or glucosuria (glucose in the urine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.